Citius Pharmaceuticals annual revenue
2011
2012
2013
2017
2018
2019
2020
2021
2022
2023
2024
2025
Citius Pharmaceuticals reported $0 in revenue for fiscal 2025.
View full Citius Pharmaceuticals company overview| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $0 | $0 | — |
| 2024 | 2024-09-30 | $0 | $0 | — |
| 2023 | 2023-09-30 | $0 | −$90,000 | −100.00% |
| 2022 | 2022-09-30 | $90,000 | $0 | 0.00% |
| 2021 | 2021-09-30 | $90,000 | $0 | 0.00% |
| 2020 | 2020-09-30 | $90,000 | $0 | 0.00% |
| 2019 | 2019-09-30 | $90,000 | $15,000 | +20.00% |
| 2018 | 2018-09-30 | $75,000 | $25,000 | +50.00% |
| 2017 | 2017-09-30 | $50,000 | — | — |
| 2013 · Sep 30 | 2013-09-30 | $0 | $0 | — |
| 2012 · Sep 30 | 2012-09-30 | $0 | $0 | — |
| 2011 | 2011-09-30 | $0 | — | — |
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | $1.5M | $1.5M | — |
| Q2 2026 | 2026-03-31 | $1.7M | $1.7M | — |
| Q1 2026 | 2025-12-31 | $3.9M | — | — |
| Q4 2025 | 2025-09-30 | $0 | — | — |
| Q3 2025 | 2025-06-30 | $0 | — | — |
| Q2 2025 | 2025-03-31 | $0 | — | — |
| Q2 2014 | 2014-06-30 | $0 | $0 | — |
| Q1 2014 | 2014-03-31 | $0 | $0 | — |
| Q4 2013 | 2013-12-31 | $0 | $0 | — |
| Q4 2013 | 2013-09-30 | $0 | $0 | — |
| Q2 2013 | 2013-06-30 | $0 | $0 | — |
| Q1 2013 | 2013-03-31 | $0 | $0 | — |
| Q4 2012 | 2012-12-31 | $0 | $0 | — |
| Q4 2012 | 2012-09-30 | $0 | $0 | — |
| Q3 2012 | 2012-06-30 | $0 | $0 | — |
| Q2 2012 | 2012-03-31 | $0 | $0 | — |
| Q1 2012 | 2011-12-31 | $0 | $0 | — |
| Q4 2011 | 2011-09-30 | $0 | — | — |
| Q3 2011 | 2011-06-30 | $0 | — | — |
| Q2 2011 | 2011-03-31 | $0 | — | — |
| Q1 2011 | 2010-12-31 | $0 | — | — |
Citius Pharmaceuticals's latest reported quarter, Q3 2026, generated $1.5M in revenue.
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Citius Pharmaceuticals source filings ↗